Minerva Surgical (UTRS) Stock Analysis & Winston Score

Minerva Surgical makes medical devices used to treat abnormal uterine bleeding, a common condition that affects millions of women. Its main product is an endometrial ablation system, which is a tool doctors use to remove the lining of the uterus as an alternative to a hysterectomy. The company sells its devices to hospitals, surgical centers, and OB-GYN physicians primarily in the United States. Minerva generates revenue by selling its single-use disposable devices, which means hospitals must keep buying new ones for each procedure. The company operates mainly in the U.S. and is a small player in the women's health device market, competing against larger, better-funded medical device companies. With an operating margin of roughly negative 61%, the company is spending significantly more than it earns, and its biggest challenge is reaching enough procedure volume to cover its costs before it runs out of cash.